Skip to content Skip to footer

The 3rd edition of the Dubai Stem Cell Congress brings together top scientists and researchers in the fields of Stem Cells & Regenerative Medicine to exchange insights, foster innovation, and advance therapies in the region. With the theme “Bridging the Future,” under the main platform “Connecting Hope,” this edition will feature inspiring patient success stories, keynote speakers, and panel discussions, with the aim of offering a beacon of hope for a brighter & healthier future. In a significant highlight, the congress will feature a Joint session in collaboration with the International Society for Cell & Gene Therapy (ISCT), further enhancing the impact of stem cell and gene therapies on the future of healthcare.

  • 00Days
  • 00Hours
  • 00Minutes
  • 00Seconds

Dear Attendees,

It gives us great pleasure to have you join us at Dubai Stem Cell Congress – 3rd Edition which will take place from 25th–26th February, 2025, at the Ritz-Carlton, Dubai International Financial Center (DIFC), to exchange thoughts and expertise in the fields of Stem Cell and Regenerative Medicine, advancing stem cell therapies in the region.

“Connecting Hope” continues to serve as our main innovative platform along with our new theme, “Bridging the Future”. This theme aims to create bridges to the latest technologies and innovations by connecting and inviting top scientists and researchers to Dubai-UAE. We’ve also curated a diverse program highlighting the latest advancements in technologies and treatments, striving to enhance the impact of stem cell research on the future of healthcare.

Discover limitless opportunities with us at the Dubai Stem Cell Congress – 3rd Edition as we unite as a global community that has an impact on healthcare across the globe. Science knows no boundaries, and neither does hope.

We look forward to welcoming you all at Dubai Stem Cell Congress.

Best Regards,
Dr. Fatma Alhashimi
Chairperson, Dubai Stem Cell Congress

Scientific Committee

Speakers

Prof. Dimitrios Mougiakakos

Director of Department of Hematology, Oncology, and Cell Therapy
Otto-von-Guericke University Magdeburg
Germany

Prof. Koichi Nakayama, MD, PhD

Professor and Chairman
Department of Regenerative Medicine and Biomedical Engineering
Faculty of Medicine
Saga University

Prof. Jun Wu, PhD

Associate Professor
Department of Molecular Biology
UT Southwestern Medical Center
Dallas, TX, USA

Prof. John E. J. Rasko, AO

Faculty of Medicine & Health,
The University of Sydney
Head of Department, Cell & Molecular Therapies,
Royal Prince Alfred Hospital,
Sydney Local Health District
Deputy Director & Head, Gene and Stem Cell Therapy Program, Centenary Institute

Dr. Essam Abdelalim, PhD

Principle Investigator
Head, Laboratory of Pluripotent
Stem Cell Disease Modeling
Sidra Medicine
Qatar

Dr. Sarkawt Hamad

Regenerative Medicine Scientist
Marga-and-Walter-Boll Laboratory for Cardiac Tissue Engineering
Germany

Prof. Kurt Pfannkuche

Medical Faculty University of Cologne
Marga-and Walter Bolls Laboratory for Cardiac Tissue Engineering
Germany

Prof. John Wagner, MD

Director of the Institute for Cell Gene and Immunotherapies
University of Minnesota
USA

Prof. Halvard B. Bönig, PhD

Professor of Transfusion Medicine, Translational Development of Cellular Therapies
Institute for Transfusion Medicine and Immunohematology
Goethe University
Frankfurt, Germany

Prof. Jennifer Yunyan Zhang, PhD

Professor 
Department of Dermatology and Pathology 
Duke University, School of Medicine  
North Carolina, USA

Dr. Shinsuke Yoshida, PhD

Senior Manager
Research and Development Center
CiRA Foundation,
Kyoto University, Japan

Mrs. Kim Petrella

Nurse Coordinator,
Umbilical Cord Blood International Educator, Trainer and Speaker
Clinical Instructor, University of Delaware
USA

Dr. Laura Barrachina Porcar, PhD

Senior Scientist “Manuel López” fellow School of Veterinary
Animal Anatomy, Embryology and Genetics
Spain

Dr. Ulf Grawunder

Co-founder & CEO
T-CURX GmbH
Würzburg, Germany

Dr. Felician Stancioiu

Medical Director
Bio-Forum Foundation
Bucharest, Romania

apl. Prof. Klaus Cichutek, PhD

Goethe University
Frankfurt/Main
Germany

Prof. Quinn P. Peterson, PhD

Senior Associate Consultant
Assistant Professor of Physiology
Physiology and Biomedical Engineering
Mayo Clinic, Rocheste, MN
USA

Prof. Jeffrey S.. Miller, MD

Professor of Medicine
Section Head, BMT and Cell Therapy
Division of Hematology, Oncology and Transplantation
Deputy Director, Masonic Cancer Center
University of Minnesota Cancer Center
Minneapolis, MN
USA

Prof. Peter Droge

Associate Professor (Emeritus)
School of Biological Sciences,
Nanyang Technological University (NTU)
Singapore

Dr. Didier Nouzies

Chairman and CEO
CORDSAVINGS SA
Stem Cells Biobank
Monthey, Switzerland

Dr. Sai Kiang Lim, PhD

Research Director
Paracrine Therapeutics
Singapore

Prof. Dr. rer. nat. Bernd Giebel

Professor, University Hospital Essen
Founder and Chief Scientific Officer
Exosla Therapeutics
Germany

Prof Ke Cheng

Professor of Biomedical Engineering
Columbia University
New York

Prof. Yi Zhang, PhD

Executive Director
Zhongyuan Cellular and Immunotherapy Laboratory
Henan, China

Dr. Khulood Mohamed Alsayegh

Head of Clinical Standards and Guidelines Section
Health Policies and Standard Department
Dubai Health Authority
UAE

Who Should Attend?

STRATEGIC PARTNERS

EXHIBITORS SPONSORS

DELEGATES SPONSORS

Quick Links

Download CME
2024 Congress Highlights

Follow Us

info@dubaistemcellcongress.com
Get Direction

© 2025. Dubai Stem Cell Congress. All Rights Reserved.